Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged &#8805;70 Years.

Lopez Bernal, Jamie; Andrews, Nick; Gower, Charlotte; Stowe, Julia; Tessier, Elise; Simmons, Ruth; Ramsay, Mary

Effects of BNT162b2 Messenger RNA Vaccine and ChAdOx1 Adenovirus Vector Vaccine on Deaths From COVID-19 in Adults Aged ≥70 Years.

Lopez Bernal, Jamie; Andrews, Nick; Gower, Charlotte; Stowe, Julia; Tessier, Elise; Simmons, Ruth; Ramsay, Mary.

Affiliation

Lopez Bernal J; Public Health England, London, United Kingdom.
Andrews N; NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Gower C; NIHR Health Protection Research Unit in Respiratory Infections, Imperial College London, London, United Kingdom.
Stowe J; Public Health England, London, United Kingdom.
Tessier E; NIHR Health Protection Research Unit in Vaccines and Immunisation, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Simmons R; Public Health England, London, United Kingdom.
Ramsay M; Public Health England, London, United Kingdom.

Clin Infect Dis ; 78(2): 349-351, 2024 02 17.

Article de En | MEDLINE | ID: mdl-37758203

Sujet(s)

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Vaccins / Vaccins anti-adénovirus / COVID-19 Limites: Adult / Humans Langue: En Journal: Clin Infect Dis Sujet du journal: DOENCAS TRANSMISSIVEIS Année: 2024 Type de document: Article Pays d'affiliation: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google